Literature DB >> 15133172

Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.

B Bolon1, G Campagnuolo, L Zhu, D Duryea, D Zack, U Feige.   

Abstract

Interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) synergistically induce and sustain arthritis. Two competing hypotheses of arthritis induction are 1) that TNF preferentially mediates inflammation, whereas IL-1 impels bone destruction, or 2) that either cytokine controls the entire process. In this study, these propositions were tested in two experiments by instilling IL-1beta or TNF-alpha into one knee of Lewis rats (n = 6/group) to incite arthritis, after which semiquantitative scores for inflammation, bone resorption, osteoclasts, and cartilage integrity were acquired. In the induction study, IL-1beta or TNF-alpha (3, 10, or 30 micro g) was given once to incite arthritis. After 2 days, IL-1beta induced significant, dose-dependent increases in inflammation (mild to marked), bone resorption (minimal to moderate), and osteoclasts (minimal to moderate). In contrast, TNF-alpha induced minimal to mild inflammation but had little impact on resorption or osteoclasts. Both IL-1 and TNF (>/=10 micro g) yielded mild cartilage degeneration. Most lesion scores in TNF-treated rats were significantly lower than those in animals given the same dose of IL-1beta. In the persistence study, rats were injected once with IL-1 or TNF (10 micro g) and maintained for 2, 3, or 7 days. IL-1beta significantly enhanced inflammation (all 3 days), bone resorption (days 2 and 3), osteoclasts (days 2 and 3), and cartilage matrix loss (days 2 and 3), whereas TNF-alpha augmented inflammation (days 2 and 3) and cartilage degeneration (day 2) but not bone resorption or osteoclasts. Thus, both IL-1beta and TNF-alpha can launch inflammation, but IL-1beta drives skeletal destruction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133172     DOI: 10.1354/vp.41-3-235

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  9 in total

Review 1.  Tendon tissue engineering: progress, challenges, and translation to the clinic.

Authors:  J T Shearn; K R Kinneberg; N A Dyment; M T Galloway; K Kenter; C Wylie; D L Butler
Journal:  J Musculoskelet Neuronal Interact       Date:  2011-06       Impact factor: 2.041

2.  Spinal GABA-B receptor modulates neutrophil recruitment to the knee joint in zymosan-induced arthritis.

Authors:  Gabriel S Bassi; David do C Malvar; Thiago M Cunha; Fernando Q Cunha; Alexandre Kanashiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-23       Impact factor: 3.000

3.  Inhibition of spinal p38 MAPK prevents articular neutrophil infiltration in experimental arthritis via sympathetic activation.

Authors:  Alexandre Kanashiro; Marcelo Franchin; Gabriel Shimizu Bassi; Dênis Augusto Reis Santana; Thiago Mattar Cunha; Fernando Queiróz Cunha; Luis Ulloa; Gerson Jonathan Rodrigues
Journal:  Fundam Clin Pharmacol       Date:  2017-12-22       Impact factor: 2.748

4.  Estradiol replacement therapy regulates innate immune response in ovariectomized arthritic mice.

Authors:  Ayda Henriques Schneider; Alexandre Kanashiro; Sabrina Graziani Veloso Dutra; Raquel do Nascimento de Souza; Flávio Protásio Veras; Fernando de Queiroz Cunha; Luis Ulloa; André Souza Mecawi; Luis Carlos Reis; David do Carmo Malvar
Journal:  Int Immunopharmacol       Date:  2019-05-02       Impact factor: 4.932

5.  The evolving systemic and local biomarker milieu at different stages of disease progression in rat adjuvant-induced arthritis.

Authors:  Marina Stolina; Brad Bolon; Scot Middleton; Denise Dwyer; Heather Brown; Diane Duryea; Li Zhu; Alison Rohner; James Pretorius; Paul Kostenuik; Ulrich Feige; Debra Zack
Journal:  J Clin Immunol       Date:  2008-08-26       Impact factor: 8.317

6.  Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators?

Authors:  Joseph Paquet; Jean-Christophe Goebel; Camille Delaunay; Astrid Pinzano; Laurent Grossin; Christel Cournil-Henrionnet; Pierre Gillet; Patrick Netter; Jean-Yves Jouzeau; David Moulin
Journal:  Arthritis Res Ther       Date:  2012-03-13       Impact factor: 5.156

Review 7.  Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.

Authors:  Brad Bolon; Marina Stolina; Caroline King; Scot Middleton; Jill Gasser; Debra Zack; Ulrich Feige
Journal:  J Biomed Biotechnol       Date:  2010-12-28

8.  UP1306: A Composition Containing Standardized Extracts of Acacia catechu and Morus alba for Arthritis Management.

Authors:  Mesfin Yimam; Teresa Horm; Laura Wright; Ping Jiao; Mei Hong; Lidia Brownell; Qi Jia
Journal:  Nutrients       Date:  2019-01-26       Impact factor: 5.717

9.  Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.

Authors:  Aftab Ahmad; Mohammed F Abuzinadah; Huda M Alkreathy; Babajan Banaganapalli; Mohd Mujeeb
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.